Carbapenem resistance in Acinetobacter baumannii, and their importance in hospital‐acquired infections: a scientific review
M Nguyen, SG Joshi - Journal of applied microbiology, 2021 - academic.oup.com
Carbapenem is an important therapy for serious hospital‐acquired infections and for the
care of patients affected by multidrug‐resistant organisms, specifically Acinetobacter …
care of patients affected by multidrug‐resistant organisms, specifically Acinetobacter …
Antimicrobial resistance in ICUs: an update in the light of the COVID-19 pandemic
R Cantón, D Gijón… - Current opinion in critical …, 2020 - journals.lww.com
The increase of antimicrobial resistance in ICUs is mainly due to the spread of HiRCs and is
exemplified with the ESKAPE Gram-negative microorganisms. The COVID-19 pandemic …
exemplified with the ESKAPE Gram-negative microorganisms. The COVID-19 pandemic …
[HTML][HTML] Acinetobacter baumannii in the critically ill: complex infections get complicated
I Cavallo, A Oliva, R Pages, F Sivori, M Truglio… - Frontiers in …, 2023 - frontiersin.org
Acinetobacter baumannii is increasingly associated with various epidemics, representing a
serious concern due to the broad level of antimicrobial resistance and clinical …
serious concern due to the broad level of antimicrobial resistance and clinical …
[HTML][HTML] Antimicrobial resistance and the spectrum of pathogens in dental and oral-maxillofacial infections in hospitals and dental practices in Germany
A Meinen, A Reuss, N Willrich, M Feig, I Noll… - Frontiers in …, 2021 - frontiersin.org
Data on microbiological profiles in odontogenic infections are scarce. This study aimed to
analyze the spectrum of pathogens and antimicrobial resistance in clinical isolates from …
analyze the spectrum of pathogens and antimicrobial resistance in clinical isolates from …
[HTML][HTML] Low proportion of linezolid and daptomycin resistance among bloodborne vancomycin-resistant Enterococcus faecium and methicillin-resistant …
R Markwart, N Willrich, T Eckmanns, G Werner… - Frontiers in …, 2021 - frontiersin.org
Vancomycin-resistant Enterococcus faecium (VREF) and methicillin-resistant
Staphylococcus aureus (MRSA) are associated with significant health burden. We …
Staphylococcus aureus (MRSA) are associated with significant health burden. We …
[HTML][HTML] Burden of illness in carbapenem-resistant Acinetobacter baumannii infections in US hospitals between 2014 and 2019
JM Pogue, Y Zhou, H Kanakamedala, B Cai - BMC Infectious Diseases, 2022 - Springer
Abstract Background Carbapenem-resistant (CR) Acinetobacter baumannii is a concerning
pathogen in the USA and worldwide. Methods To assess the comparative burden of CR vs …
pathogen in the USA and worldwide. Methods To assess the comparative burden of CR vs …
High-resolution bacterial cytological profiling reveals Intrapopulation morphological variations upon antibiotic exposure
T Samernate, HH Htoo, J Sugie… - Antimicrobial Agents …, 2023 - Am Soc Microbiol
Phenotypic heterogeneity is crucial to bacterial survival and could provide insights into the
mechanism of action (MOA) of antibiotics, especially those with polypharmacological …
mechanism of action (MOA) of antibiotics, especially those with polypharmacological …
[HTML][HTML] Isolation and Characterization of a Novel Siphoviridae Phage, vB_AbaS_TCUP2199, Infecting Multidrug-Resistant Acinetobacter baumannii
M Mardiana, SH Teh, LC Lin, NT Lin - Viruses, 2022 - mdpi.com
Multidrug-resistant Acinetobacter baumannii (MDRAB) is a pathogen recognized as
antimicrobial-resistant bacteria involved in healthcare-associated infections. Resistance to …
antimicrobial-resistant bacteria involved in healthcare-associated infections. Resistance to …
[HTML][HTML] Risk factors and outcomes of bloodstream infections caused by Acinetobacter baumannii: a case–control study
Y Gu, Y Jiang, W Zhang, Y Yu, X He, J Tao… - … and Infectious Disease, 2021 - Elsevier
The risk factors and outcomes of patients with bloodstream infections (BSIs) caused by
Acinetobacter baumannii are major concerns in clinical therapy. Multicenter case–control …
Acinetobacter baumannii are major concerns in clinical therapy. Multicenter case–control …
[HTML][HTML] Trends in the bacterial prevalence and antibiotic resistance patterns in the acute exacerbation of chronic obstructive pulmonary disease in hospitalized …
M Kaleem Ullah, S Malamardi, JB Siddaiah, A Prashant… - Antibiotics, 2022 - mdpi.com
Exacerbation due to antimicrobial-drug-resistant bacteria among chronic obstructive
pulmonary disease (AECOPD) patients contributes to mortality and morbidity. We examined …
pulmonary disease (AECOPD) patients contributes to mortality and morbidity. We examined …